A "No-Wash" Albumin-Dextran Dilution Strategy for Cord Blood (CB) Thaw is Associated with a High Rate of Engraftment and a Low Incidence of Serious Infusion Reactions (Englisch)
- Neue Suche nach: Rice, R. D.
- Neue Suche nach: Abboud, M.
- Neue Suche nach: Hawke, R. M.
- Neue Suche nach: Schaible, A. M.
- Neue Suche nach: Heller, G.
- Neue Suche nach: Scaradavou, A.
- Neue Suche nach: Barker, J. N.
- Neue Suche nach: Rice, R. D.
- Neue Suche nach: Abboud, M.
- Neue Suche nach: Hawke, R. M.
- Neue Suche nach: Schaible, A. M.
- Neue Suche nach: Heller, G.
- Neue Suche nach: Scaradavou, A.
- Neue Suche nach: Barker, J. N.
In:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
;
15
, 2
;
45
;
2009
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:A "No-Wash" Albumin-Dextran Dilution Strategy for Cord Blood (CB) Thaw is Associated with a High Rate of Engraftment and a Low Incidence of Serious Infusion Reactions
-
Beteiligte:Rice, R. D. ( Autor:in ) / Abboud, M. ( Autor:in ) / Hawke, R. M. ( Autor:in ) / Schaible, A. M. ( Autor:in ) / Heller, G. ( Autor:in ) / Scaradavou, A. ( Autor:in ) / Barker, J. N. ( Autor:in )
-
Erschienen in:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION ; 15, 2 ; 45
-
Verlag:
- Neue Suche nach: Elsevier Science B. V. Amsterdam
-
Erscheinungsdatum:01.01.2009
-
Format / Umfang:45 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 617.4
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 617.4 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 15, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Epigenetic Modulation of Foxp3: Generation of CD4+CD25- T Cells with a Suppressor PhenotypeChoi, J. / Schroeder, M. / Ritchey, J. / DiPersio, J. F. et al. | 2009
- 1
-
Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and EfficacyHoyos, V. / Savoldo, B. / Vera, J. F. / Quintarelli, C. / Heslop, H. / Rooney, C. M. / Brenner, M. K. / Dotti, G. et al. | 2009
- 1
-
Depletion of Vascular Endothelial Progenitor Cells Simultaneously Ameliorates GVHD and Inhibits Tumor GrowthPenack, O. / Henke, E. / Suh, D. / King, C. / Smith, M. / Na, I. K. / Holland, A. / Ghosh, A. / Lu, S. / Jenq, R. et al. | 2009
- 3
-
Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation StudyMacMillan, M. L. / Blazar, B. R. / DeFor, T. E. / Ma, L. / Tolar, J. / Zierhut, H. / Wagner, J. E. et al. | 2009
- 3
-
The Relapse-Free Survival Benefit Associated with Group B KIR Haplotype Donors for Unrelated Hematopoietic Cell Transplantation is Unique to Acute Myelogenous LeukemiaCooley, S. / Parham, P. / Trachtenberg, E. / Luo, X. / Le, C. T. / Klein, J. / Marsh, S. G. / Weisdorf, D. J. / Miller, J. S. et al. | 2009
- 4
-
Pediatric BMT for Malignancy Using Zero/One Antigen Mismatched Family Donors or Unrelated Donors Have Similar Outcomes, Both of Which Are Inferior to Matched Sibling DonorsShaw, P. J. / Kan, F. / Ahn, K. W. / Spellman, S. R. / Davies, S. M. / Pulsipher, M. A. / Petersdorf, E. W. / Klein, J. / Lee, S. J. / Others, o. b. et al. | 2009
- 5
-
Evaluation of Rabbit Antithymocyte Globulin (rATG) Dose-Intensity in Patients Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Reduced Intensity Conditioning (RIC) with Fludarabine, Busulfan and rATG (FBA)Hamadani, M. / Benson, D. M. / Porcu, P. / Elder, P. / Andritsos, L. / Hofmeister, C. C. / Krugh, D. / Garzon, R. / Lin, T. / Marcucci, G. et al. | 2009
- 5
-
Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 PatientsBrunstein, C. G. / Weisdorf, D. J. / DeFor, T. E. / Miller, J. S. / McGlave, P. B. / Blazar, B. R. / Wagner, J. E. et al. | 2009
- 5
-
Fludarabine, Cyclophosphamide with or without Low Dose TBI for Alternative Donor Transplants in Acquired Aplastic Anemia (SAA): A Report From the EBMT-SAA Working PartyBacigalupo, A. / Locatelli, F. / Lanino, E. / Marsh, J. / Socie, G. / Passweg, J. et al. | 2009
- 5
-
Genomic Instability After Allogeneic HCT: Frequent in Oral and Rare in Nasal Mucosal CellsKhan, F. / Sy, S. / Louie, P. / Quinlan, D. / Stewart, D. / Russell, J. / Storek, J. et al. | 2009
- 6
-
Hypoalbuminemia (< 3.0 g/dl) and Poor Karnofsky Performance (KPS<80) at Day +90 Are Independent Predictors of Worse Non-Relapse Survival (NRS) and Overall Survival (OS) in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients: Results of a Multivariable AnalysisKharfan-Dabaja, M. A. / Chavez, J. C. / Fernandez-Vertiz, E. I. / Yu, D. / Zhu, W. / Perkins, J. / Field, T. / Ayala, E. / Fernandez, H. / Alsina, M. et al. | 2009
- 6
-
Rapid Immunosuppression Taper Following Reduced Intensity HCT From Related Donor Is Tolerable But Does Not Improve Outcomes of Advanced Hematologic MalignanciesKrijanovski, O. / Krijanovski, Y. / Khaled, Y. / Cummings, T. / Braun, T. / Reddy, P. / Peres, E. / Mineishi, S. / Kitko, C. / Choi, S. et al. | 2009
- 7
-
Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) From Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). A Long-Term Follow-Up (10 Years) Study From the EBMT RegistryMichallet, M. / Le, Q. H. / Dreger, P. / Sobh, M. / Niederwieser, D. / Koza, V. / Ruutu, T. / Russel, N. / Verdonck, L. / Milligan, D. et al. | 2009
- 7
-
The Economic Costs to us Hospitals of Invasive Fungal Infections in Hematopoietic Stem Cell and Bone Marrow Transplant PatientsMenzin, J. / Jackel, J. L. / Friedman, M. / Korn, J. R. / Perfect, J. / Langston, A. / Prasad, M. / Papadopoulos, G. et al. | 2009
- 8
-
Langerhans Cell Chimerism After Myeloablative Versus Nonmyeloablative Hematopoietic Cell TransplantationKirkorian, Y. / Collin, M. / Leboeuf, M. / Bogunovic, M. / Wood, B. / Hackman, R. C. / Storer, B. / Storb, R. / Merad, M. / Mielcarek, M. et al. | 2009
- 8
-
Practice Patterns for Evaluation, Consent and Care of Related Donors and Recipients At Hematopoietic Stem Cell Transplant Centers in the United States: Is Conflict-of-Interest an Unrecognized Issue?ODonnell, P. / Pedersen, T. / Confer, D. / Pulsipher, M. / Rizzo, J. D. / Stroncek, D. / Leitman, S. / Anderlini, P. et al. | 2009
- 9
-
BK Virus Infection is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell TransplantsODonnell, P. H. / Swanson, K. / Josephson, M. A. / Artz, A. S. / Rich, E. / Stock, W. / van Besien, K. et al. | 2009
- 9
-
Natural Killer (NK) Cells Are Resistant to the Apoptotic Effects of Corticosteroids Compared to T Cells: Implications for Adoptive NK Cell Therapy Following Allogeneic HCTRamanathan, M. / Lundqvist, A. / Yokoyama, H. / Smith, A. / Childs, R. et al. | 2009
- 9
-
HHV6 Reactivation is an Important Riskfactor for Poor Outcomes in Myeloablative, But Not in Non-Myeloablative Treated Allogeneic HSCT PatientsPagter, A. P. / Meijer, E. / Keukens, L. / Schutten, M. / Cornelissen, J. J. / Baarle, D. / Fries, E. / Schuurman, R. / Boelens, J. J. et al. | 2009
- 10
-
Pre-Transplant Risk Assessment in Adult Acute Lymphocytic LeukemiaTerwey, T. H. / Massenkeil, G. / le Coutre, P. / Hemmati, P. / Neuburger, S. / Dorken, B. / Arnold, R. et al. | 2009
- 10
-
In Situ Activation of Host CD4+ CD25+ FoxP3+ T Cells: A New Strategy for Circumventing Resistance and Establishment of Hematopoietic Engraftment After MHC-Matched Allogeneic HCTShatry, A. / Levy, R. B. et al. | 2009
- 11
-
Ex Vivo Expansion of Human Cord Blood Progenitor Cells with the Notch Ligand Delta1 Results in Rapid Myeloid Reconstitution In Vivo Following Myeloablative Cord Blood TransplantationDelaney, C. / Brashem-Stein, C. / Voorhies, H. / Gutman, J. / Heimfeld, S. / Bernstein, I. D. et al. | 2009
- 11
-
Treatment-Related Mortality in Patients with AL Amyloidosis Undergoing High-Dose Melphalan and Stem Cell Transplantation: Trend Over The Past 14 Years at a Single InstitutionSanchorawala, V. / Skinner, M. / Finn, K. T. / Quillen, K. / Seldin, D. C. et al. | 2009
- 11
-
Comparison of Graft Durability Among Lymphoma Patients Who Received Plerixafor in Combination with G-CSF for Primary Versus Failed MobilizationMicallef, I. N. / Stiff, P. J. / DiPersio, J. F. / Maziarz, R. T. / McCarty, J. M. / Angell, J. / Bridger, G. / Calandra, G. et al. | 2009
- 12
-
Flagellin, A TLR5 Agonist, Facilitates Production of foxp3+CD4+CD25+ Regulatory T Cells to Maintain Balanced Immune Reconstitution in Allogeneic BMT without GvHDHossain, M. S. / Roback, J. D. / Gewirtz, A. T. / Waller, E. K. et al. | 2009
- 12
-
Targeted Protection of the Colon in the Absence of Donor Antigen-Presenting Cell -Derived Interleukin 23 Allows for Separation of Graft Versus Host and Graft Versus Leukemia EffectsDas, R. / Drobyski, W. R. et al. | 2009
- 12
-
Lymphocyte Recovery is a Major Determinant of Transplant Outcome After Myeloablative Transplantation in Patients with Myeloid Malignancies Receiving Matched Unrelated Stem Cell AllograftsLe Blanc, K. / Remberger, M. / Barrett, J. et al. | 2009
- 13
-
Adoptive Transfer of NKT Cells Reduces GVHD Severity Via an IFN-g And IL-4 Dependent MechanismLeveson-Gower, D. B. / Olson, J. A. / Sega, E. I. / Baker, J. / Zeiser, R. / Negrin, R. S. et al. | 2009
- 13
-
Elafin is a Biomarker of Graft Versus Host Disease of the SkinPaczesny, S. / Levine, J. E. / Hogan, J. / Crawford, J. / Braun, T. M. / Wang, H. / Faca, V. / Zhang, Q. / Pitteri, S. / Chin, A. et al. | 2009
- 13
-
Ceacam1 Regulates Experimental Graft-Versus-Host-DiseaseLu, S. X. / Willis, L. / Charbonneau-Allard, A. M. / Atallah, R. / Holland, A. M. / Turbide, C. / Hubbard, V. M. / Rotolo, J. A. / Smith, O. M. / Suh, D. et al. | 2009
- 14
-
Host Natural Killer T Cells Induce an IL-4 Dependent Expansion of Donor CD4+CD25+Foxp3+ Tregs That Protects Against Lethal Acute Graft-Versus-Host DiseasePillai, A. B. / George, T. I. / Dutt, S. / Strober, S. et al. | 2009
- 14
-
Donor KIR 3DS1 is Associated with Less Acute GvHD Following Unrelated Allogeneic Hematopoietic Cell Transplantation for Hematologic MalignanciesVenstrom, J. M. / Gooley, T. A. / Spellman, S. R. / Hasan, R. S. / Pring, J. A. / Malkki, M. / Dupont, B. / Petersdorf, E. W. / Hsu, K. C. et al. | 2009
- 15
-
In Vivo Modulation of T Cell and Monocyte Function Following Infusion of Mesenchymal Stromal Cells (MSC)Castilla-LLorente, C. / Mielcarek, M. / Iwata, M. / Abrams, V. K. / Hwang, B. / Nash, R. A. / Torok-Storb, B. et al. | 2009
- 15
-
National Institutes of Health Lung Function Score as a Potential Marker for the Development of Chronic Graft-Versus-Host DiseaseWalter, E. C. / Vigorito, A. / Campregher, P. V. / Martin, P. / Flowers, M. / Chien, J. W. et al. | 2009
- 15
-
Co-Transplantation of Cord Blood with Whartons Jelly Derived Umbilical Cord - Mesenchymal Stem Cell S (UC-MSC) Improves Short Term Myeloid Engraftment into NOD/SCID/IL-2Rgnull micePaganessi, L. A. / Walker, A. L. / Fung, H. C. / Christopherson, K. W. et al. | 2009
- 16
-
Cord Blood (CB) Extends Transplant Access to Racial and Ethnic Minorities: A Prospective Study of 309 Unrelated Searches in Patients with High-Risk Hematologic MalignanciesLee, S. S. / Scaradavou, A. / Hawke, R. M. / Webb, K. A. / Wells, D. S. / Abboud, M. / Papadopoulos, E. B. / Kernan, N. A. / Barker, J. N. et al. | 2009
- 16
-
Improved Engraftment in an NOD-SCID IL-2Rgnull Mouse Model Following Transplantation of Fucosylated Cord Blood Mononuclear CellsRobinson, S. N. / Yang, H. / Decker, W. K. / Xing, D. / Steiner, D. / Simmons, P. J. / Miller, L. / Cooper, L. J. / de Lima, M. J. / Champlin, R. E. et al. | 2009
- 16
-
Pre-Engraftment Syndrome (PES): A Clinical Syndrome After Cord Blood (CB) Transplantation Not Associated with Acute Graft-Versus-Host Disease (aGvHD) or Transplant-Related Mortality (TRM)Patel, K. J. / Rice, R. D. / Hawke, R. M. / Abboud, M. / Heller, G. / Scaradavou, A. / Barker, J. N. et al. | 2009
- 17
-
Cytotoxic T Lymphocytes (CTL) Specific for Adenovirus and CMV Can Be Generated From Umbilical Cord Blood for Adoptive ImmunotherapyHanley, P. / Savoldo, B. / Cruz, C. R. / Leen, A. M. / Molldrem, J. J. / Liu, H. / Gee, A. P. / Heslop, H. E. / Dotti, G. / Shpall, E. J. et al. | 2009
- 17
-
Negative Impact of Post-Thaw Washing on the Overall Survival (OS) and Disease Free Survival (DFS) of Patients Receiving Plasma Depleted (PD) Cord Blood (CB) TransplantationChow, R. / Law, P. / Wang, B. / Rosenthal, J. / Nademanee, A. / Karanes, C. / Jaing, T. H. / Graham, M. L. / Delaney, C. / Gjertson, D. et al. | 2009
- 18
-
The Effect of Inhibitory Killer-Cell Ig-Like Receptor(iKIR) Matching in Allogeneic Hematopoietic Cell Transplantation(HCT)Senitzer, D. / Sun, J. Y. / Gaidulis, L. / Oki, A. / Dagis, A. / Palmer, J. / Forman, S. J. et al. | 2009
- 18
-
In Utero Gene and Cell Therapy for Congenital DiseaasesPorta, F. / Lorenzi, L. / Bolda, F. / Bosi, A. / Gaspar, H. B. / Lanfranchi, A. et al. | 2009
- 18
-
The "Marrowminer", A Novel, Minimally Invasive Device for the Harvest of Bone Marrow: Results From the Marvelous Trial Demonstrate Safety, Efficacy and Improved Stem Cell Yields Compared to Standard Marrow Harvest MethodKraft, D. / Crocker, M. / Ramella, O. / Ghazarossian, V. / Carrasco Yalan, A. et al. | 2009
- 19
-
Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant RecipientsGerdemann, U. / Christin, A. / Fujita, Y. / Vera, J. F. / Ramos, C. A. / Dilloo, D. / Brenner, M. K. / Heslop, H. E. / Rooney, C. M. / Leen, A. M. et al. | 2009
- 19
-
Rapid Recovery of Absolute Lymphocyte Counts (ALC) is Predictive of Favorable Outcomes Following Umbilical Cord Blood (UCB) Transplantation: Impact of the Use of Two UCB UnitsVerneris, M. R. / Janardan, S. / Isaksson, R. / Brunstein, C. G. / Weisdorf, D. J. / Miller, J. S. / Wagner, J. E. et al. | 2009
- 19
-
Donor Lymphocyte Infusions Depleted of Alloreactive T Cells Decrease Infections without Causing GVHD After Haplotype Mismatched Myeloablative Stem Cell TransplantationRoy, D. C. / Cohen, S. / Busque, L. / Fish, D. / Kiss, T. / Lachance, S. / Sauvageau, G. / Rovers, J. / Roy, J. et al. | 2009
- 20
-
Relapse and Mortality in Young Survivors 2.5 Years After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Solid Organ Tumors and Malignant Blood DisordersHutspardol, S. / Shaw, P. J. et al. | 2009
- 20
-
Measuring the Symptom Burden of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With and Without Acute Graft-Versus-Host DiseaseWilliams, L. A. / Giralt, S. A. / Wang, X. S. / Mobley, G. M. / Mendoza, T. R. / Cohen, M. Z. / Cleeland, C. S. et al. | 2009
- 20
-
The Impact of Full Dose Total Body Irradiation(TBI)-Containing Conditioning on Chronic Kidney Disease and Thrombotic Microangiopathic Anemia in Allogeneic Hematopoietic Stem Cell Transplantation(HSCT)Glezerman, I. / Jhaveri, K. / Papadopouolos, E. B. / Flombaum, C. / Jakubowski, A. A. et al. | 2009
- 21
-
Impact of Cytogenetics Risk on Outcome After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) From an HLA Identical Sibling for Patients With Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)Mohty, M. / Labopin, M. / Milpied, N. / Cornelissen, J. J. / Blaise, D. / Petersen, E. / Theorin, N. / Goker, H. / Socie, G. / Rocha, V. et al. | 2009
- 21
-
Risks and Benefits of Unrelated Donor Peripheral Blood Progenitor Cell S (PBSC) in Children and Adolescents With Acute LeukemiaRingden, O. / Eapen, M. / Locatelli, F. / Champlin, R. E. / Frangoul, H. A. / Remberger, M. / Gee, A. P. / Laughlin, M. J. / Rocha, V. et al. | 2009
- 22
-
Complete Tumor Responses in Lymphoma Patients Who Receive Autologous Cytotoxic T Lymphocytes Targeting EBV Latent Membrane ProteinsBollard, C. M. / Stanojevic, M. / Leen, A. M. / Lopez, T. / Sheehan, A. / Carrum, G. / Liu, H. / Chang, C. C. / Gee, A. P. / Brenner, M. K. et al. | 2009
- 22
-
Long-Term Survival and Late Relapse in 2-Year Survivors of Autologous Hematopoietic Cell Transplantation for LymphomaMajhail, N. S. / Wang, Z. / Zhang, M. J. / Lazarus, H. M. / Bajorunaite, R. / Rizzo, J. D. et al. | 2009
- 22
-
HLA-Identical Allogeneic Stem Cell Transplantation (alloSCT) for Patients With Primary Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Analysis of the Lymphoma Working Party of the European Blood and Marrow Transplantation Group (EBMT-LWP)Duarte, R. F. / Canals, C. / Onida, F. / Olavarria, E. / Arcese, W. / Ferrant, A. / Narni, F. / Lambertenghi, G. / Bacigalupo, A. / Bunjes, D. et al. | 2009
- 23
-
A Pilot Study of Reduced Intensity Conditioning (RI) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism in Patients With Symptomatic Sickle Cell Disease (SCD)Bhatia, M. / Morris, E. / Moore, V. / Tallamy, B. / George, D. / Garvin, J. H. / Satwani, P. / Schwartz, J. / Foley, S. / Hawks, R. et al. | 2009
- 23
-
Genetic Modification of Antigen-Specific Cytotoxic T Lymphocytes (CTLS) Restores Their Ability to Respond to Interleukin-7 (IL-7)Vera, J. F. / Hoyos, V. / Savoldo, B. / Quintarelli, C. / Attianese Greta, G. / Leen, A. M. / Liu, H. / Foster, A. E. / Heslop, H. E. / Rooney, C. M. et al. | 2009
- 24
-
High Throughput Non-Viral Gene Transfer of T Cells by Micro-Electroporators to Generate CD19-Specific Cells for Immediate InfusionChoi, Y. / Maiti, S. / Yuen, C. / Huls, H. / Biswal, S. L. / Raphael, R. / Killian, T. C. / Stark, D. J. / Lee, D. A. / Shpall, E. J. et al. | 2009
- 24
-
Adenovirus DNA Positivity in Nasopharyngeal Fluid Preceeding Haematopoietic Stem Cell Transplantation: A Very Strong Predictor for Adenovirusreactivation in Pediatric Patientsde Pagter, A. P. / Haveman, L. / Schuurman, R. / Bierings, M. B. / Boelens, J. J. et al. | 2009
- 24
-
Unrelated Cord Blood Transplantation (UCBT) of 30 Consecutive Patients With Transfusion-Dependent b-Thalassemia From A Single CenterJaing, T. H. / Wang, B. / Gjertson, D. / Petz, L. / Chow, R. et al. | 2009
- 25
-
Favorable Outcomes in Patients With Malignant Infantile Osteopetrosis Following Haploidentical Transplantation Using A Reduced Intensity Preparative RegimenKasow, K. A. / Kaste, S. C. / Lovins, R. / Wright, N. L. / Leung, W. / Hale, G. A. / Horwitz, E. M. et al. | 2009
- 25
-
Treosulfan in Conditioning Regimens in Children With Non-Malignant Disorders, Including Aplastic Anaemia-High Rate of Stable Engraftment and Low Transplant-Related MortalityKalwak, K. / Owoc-Lempach, J. / Gorczynska, E. / Porwolik, J. / Ussowicz, M. / Musial, J. / Wojcik, D. / Pazdzior, D. / Skarzynska, M. / Dyla, A. et al. | 2009
- 26
-
A Pilot Study of Tumor Lysate-Pulsed Dendritic Cell Vaccine in Pediatric High-Risk Solid Tumor Patients Following HCT: Preliminary ResultsLevine, J. E. / Adepoju, L. J. / Molitor, M. / McEwen, E. / Hutchinson, R. J. / Mody, R. / Mouro, D. / Whitfield, J. / Yanik, G. A. / Geiger, J. D. et al. | 2009
- 26
-
Treatment of High-Risk Neuroblastoma with Adoptively Transferred T Lymphocytes Genetically Engineered to Recognize GD2Louis, C. U. / Pule, M. A. / Savoldo, B. / Myers, G. D. / Rossig, C. / Russell, H. V. / Dotti, G. / Huls, M. H. / Liu, E. / Gee, A. et al. | 2009
- 27
-
Unrelated Umbilical Cord Blood Transplantation From A Single 4/6 Matched Unit is an Effective Therapy for Children With Malignant and Non-Malignant Diagnoses: Good Survival, Low Graft Failure and Graft-vs-Host Disease in a Single Center Analysis of 314 PatientsPrasad, V. K. / Mendizabal, A. / Gill, P. / Parikh, S. H. / Szabolcs, P. / Driscoll, T. A. / Page, K. / Wood, S. / Semmel, D. / Martin, P. L. et al. | 2009
- 27
-
Ambulatory Hematopoietic Stem Cell Transplant (HSCT) for Severe Primary Immunodeficiency (PID) in ChildrenTse, W. T. / Guarino, J. / Schneiderman, J. / Duerst, R. / Jacobsohn, D. / Chaudhury, S. / Kletzel, M. et al. | 2009
- 27
-
Immune Reconstitution After Gene Therapy (GTx) for Adenosine Deaminase Deficient Severe Combined Immune Deficiency (ADA-SCID)Sokolic, R. / Podsakoff, G. / Muul, L. / Engel, B. / Jagadeesh, J. / Garabedian, E. / Kesserwan, C. / Carbonaro, D. / Choi, Y. C. / Shaw, K. et al. | 2009
- 28
-
Identification and Isolation of the Hematopoietic Stem Cell Niche Initiating Cell PopulationKraft, D. / Chan, C. / Chen, C. C. / Luppen, C. / Weissman, I. L. et al. | 2009
- 28
-
Adoptive Transfer of HER2-Specific T Cells Eradicates Experimental Glioblastoma MultiformeSalsman, V. S. / Kew, Y. / Powell, S. Z. / Wels, W. E. / Grossman, R. / Heslop, H. E. / Gottschalk, S. / Ahmed, N. et al. | 2009
- 28
-
Impact Of Reduced Intensity Conditioning (RIC) in Pediatric Acute Lymphoblastic Leukemia (ALL): A Report From the CIBMTRVerneris, M. R. / Burke, M. J. / He, W. / Davies, S. M. / Eapen, M. / Wagner, J. E. et al. | 2009
- 29
-
New Mobilization Strategies for Collection of Peripheral Blood Progenitor Cells for Lymphoma and Myeloma PatientsSmith, V. R. / Hosing, C. / Popat, U. / Schindler, J. et al. | 2009
- 29
-
Depletion of CD3+ and/or CD14+ Cells From Cord Blood Improves Ex Vivo ExpansionYang, H. / Robinson, S. N. / Decker, W. K. / Xing, D. / Steiner, D. / Lu , de Lima M.J., J. / Champlin, R. E. / Simmons, P. J. / Shpall, E. J. et al. | 2009
- 30
-
Perspective of Bone Marrow Transplant Nurses in the United States (US) and Europe (EU) of Unmet Educational NeedsDevine, H. / Schmit-Pokorny, K. / Tierney, D. K. / McDermott, K. et al. | 2009
- 30
-
The Development of a BMT-Specific Acuity Tool for the Outpatient Treatment CenterThirlwell, S. / Siderakis, C. / Gillespie, M. / Ziel, N. / Bazzi, K. / Leverett, R. / Moore, S. / Odom, M. / Simanteris, D. / Vann, V. et al. | 2009
- 30
-
A Little Structure Goes A Long Way: An Innovative Orientation Program for BMT Nurse CoordinatorsLarson, S. M. et al. | 2009
- 31
-
Long-Term Follow-Up of Patients After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Regard to QOL and Social Functioning in Chronic GVHD: A Single-Institute AnalysisMori, A. / Yamada, M. / Wada, N. / Fujii, E. / Mori, M. / Tanosaki, R. / Yamamoto, S. / Araki, M. / Takaue, Y. et al. | 2009
- 31
-
Stories and Music for Adolescent/Young Adult: Resilience During TransplantHaase, J. A. / Robb, S. L. / Burns, D. S. / Stegenga, K. / Haut, P. R. / Rimkus, C. et al. | 2009
- 31
-
The Efficacy of Oral Glutamine as a Preloaded Medicine in Reducing the Severity and Duration of Mucositis in the Pediatric Stem Cell Transplant SettingGaree, A. M. / Termuhlen, A. M. / Skeens, M. A. / Rosselet, R. M. / Ryan-Wenger, N. et al. | 2009
- 32
-
Psychosocial Adjustment in Long Term Survivors of Allogeneic HSCT: A Comparison of Patients Treated with Myeloablative (MC) and Reduced Intensity Conditioning (RIC) RegimensBevans, M. / Mitchell, S. / Wehrlen, L. / Prachenko, O. / Soeken, K. / Koklanaris, E. / Cook, L. / Odom, J. / Prince, P. / Le, Q. et al. | 2009
- 32
-
Easing the TBI Experience in the Pre-School PatientCash, J. V. / Sweezy, C. M. / Browne-Topete, A. / Martin, P. L. / Georgas, D. L. / Larrier, N. A. et al. | 2009
- 32
-
Implications for Nurses and the Supportive Care Needs for Children Undergoing Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (RIC-AlloSCT)Barrell, C. / Dietzen, D. / Shonfeld, T. / Pinchefsky, S. / Satwani, P. et al. | 2009
- 33
-
Impact of a Pharmacist in the Outpatient Allogeneic Stem Cell Transplant ClinicBurzynski, J. A. / Craver, L. F. / Geerdes, P. A. / Perreault, S. K. / Litzow, M. R. / Hogan, W. J. / Elliott, M. A. / Wolf, R. C. et al. | 2009
- 33
-
Nursing Care of the Bone Marrow Transplant Patient With Hemorrhagic CystitisEron, B. / Talbert, G. / Shea, T. et al. | 2009
- 33
-
Time is money!: Cost Analysis of Nursing Salary Expenditure and Time Savings by Utilizing the Biopatch Dressing for Central Venous Catheters on an Inpatient Bone Marrow Transplant UnitCunningham, B. / Devine, D. / Harvey, K. et al. | 2009
- 34
-
Development and Comparison of Limited Sampling Strategies for Pharmacokinetically-Guided High-Dose, Intravenous BusulfanKazerooni, R. / Madden, T. / McAdams, P. / de Lima, M. / Jones, R. B. / Kebriaei, P. / Champlin, R. / Andersson, B. et al. | 2009
- 34
-
Famciclovir Prophylaxis of Varicella Zoster Virus Reactivation in Children After Hematopoeitic Stem Cell TransplantationCharbonneau-Allard, A. M. / Therrien, R. et al. | 2009
- 34
-
Medactionplan.com As a Tool for Patient Education and Medication Management in the Blood and Marrow Transplant SettingChuang, W. / Pineiro, M. J. / Ginsburg, A. / Reyes, A. / Ueng, C. / Matta, C. / Taschek, M. / Agura, E. A. / Berryman, R. B. / Pineiro, L. A. et al. | 2009
- 36
-
Incidence of CMV Infection in Autoimmune Diseases After Autologous Stem Cell TransplantationPieroni, F. / Stracieri, A. B. / Oliveira, M. C. / Morais, D. A. / Barros, G. M. / Madeira, M. I. / Simoes, B. P. / Voltarelli, J. C. et al. | 2009
- 36
-
Comparison of Clinical Outcomes of Relapsed APL Patients Induced With ATO and Consolidated With Either an Autologous SCT or ATO Based Treatment RegimenMathews, V. / George, B. / Lakshmi, K. M. / Chendamarai, E. / Viswabandya, A. / Srivastava, A. / Chandy, M. et al. | 2009
- 36
-
Cutaneous Microvasculature of Human Chronic GVHD Lacks the Vascular Rarefaction or the Abnormal Endothelial Cell Phenotype of Systemic SclerosisFleming, J. N. / Shulman, H. M. / Schwartz, S. M. et al. | 2009
- 37
-
Plerixafor Can Predictably Mobilize Hematopoietic Stem Cells in Patients With Multiple Myeloma Previously Treated With LenalidomideTarantolo, S. R. / McSweeney, P. A. / Micallef, I. N. / Klein, L. M. / Calandra, G. / Huebner, D. et al. | 2009
- 37
-
Effect of Plerixafor (AMD 3100) Plus G-CSF on Tumor Cell Mobilization Among Patients With LymphomaDiPersio, J. F. / Bridger, G. / Calandra, G. et al. | 2009
- 38
-
Day 15 Interleukin 15 Levels Affect Natural Killer Cell Recovery After Autologous Stem Cell TransplantationPorrata, L. F. / Inwards, D. J. / Micallef, I. N. / Johnston, P. B. / Ansell, S. M. / Markovic, S. N. et al. | 2009
- 38
-
CD34+ Cell Yield on Day 1 of Apheresis Predicts Total CD34+ Cell Mobilization, Neutrophil Recovery, and Survival After Autologous Stem Cell Transplantation for LymphomaDean, R. / Rybicki, L. / Pohlman, B. / Sweetenham, J. / Sobecks, R. / Copelan, E. / Kalaycio, M. / Smith, S. / Andresen, S. / Bolwell, B. et al. | 2009
- 38
-
Mobilization With Chemotherapy Compared to G-CSF Alone: An Analysis of Resource Use and Cost in Autologous Stem Cell Transplant PatientsPelletier, E. M. / Smith, P. J. / Dembek, C. J. et al. | 2009
- 39
-
Immunotherapy With Rituximab (RITUXAN)/Interleukin 2 (IL-2) Following Autologous Peripheral Blood Stem Cell Transplant (ASCT) as Treatment for CD20 Positive Non-Hodgkins LymphomaHolmberg, L. A. / Maloney, D. G. / Bensinger, W. I. et al. | 2009
- 39
-
Physical Performance Factors and Overall Survival After Autologous and Allogeneic BMTHahn, T. / Smiley, S. L. / Tan, W. / Wilding, G. / Thomas, J. / Fassl, K. / Wright, C. / Battiwalla, M. / McCarthy, P. L. et al. | 2009
- 39
-
Autologous Hematopoeitic Stem Cell Transplantation (HSCT) in Patients With Acute Myeloid Leukemia (AML) in First or Second RemissionNaqvi, H. / John, V. / Devoe, C. / Kiner, B. / Kolitz, J. / Allen, S. / Gissinger, D. / Cannon, M. / Fitzgerald, E. / Klocke, J. et al. | 2009
- 40
-
Autologous Stem Cell Transplantation (ASCT) With a PCR-Negative Graft Was Associated With a Favorable Outcome for Core-Binding-Factor Acute Myeloid Leukemia (CBF-AML)Nakasone, H. / Izutsu, K. / Wakita, S. / Yamaguchi, H. / Muramatsu-Kida, M. / Usuki, K. et al. | 2009
- 40
-
Febrile Reactions Occurring With Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients With AL Amyloidosis: A "Melphalan Recall" ReactionRosenzweig, M. A. / Seldin, D. C. / Remick, D. / Skinner, M. / Quillen, K. / Oran, B. / Finn, K. T. / Sanchorawala, V. et al. | 2009
- 40
-
Pre-Transplant Clonal Cytogenetic Abnormalities in Stem Cells Used for Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma is a Predictor of RelapseRojas, A. M. / De Vos, S. / Pinter-Brown, L. / Paquette, R. / Schiller, S. / Territo, M. C. et al. | 2009
- 40
-
Clinical Pathways and Standard Operating Procedures: Essential Tools for Outpatient Stem Cell Transplant Programs Treating Patients With AL AmyloidosisFinn, K. T. / Fennessey, S. / Yanarella, L. / Antonelli, C. / Shelton, A. / Daniel, S. / Skinner, M. / Seldin, D. / Quillen, K. / Sanchorawala, V. et al. | 2009
- 41
-
Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients With Multiple MyelomaKazmi, S. M. / Parikh, G. C. / Lahoti, A. / Mendoza, F. / Hosing, C. / Popat, U. / Alousi, A. M. / Weber, D. M. / Wang, M. / Champlin, R. E. et al. | 2009
- 41
-
Cytoreductive Regimen Containing Ranimustine (MCNU), Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Relapsed or Refractory LymphomaAsakura, Y. / Tanosaki, R. / Kim, S. W. / Azuma, T. / Kurosawa, S. / Yakushijin, K. / Maruyama, D. / Mori, S. i. / Fukuda, T. / Watanabe, T. et al. | 2009
- 41
-
Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM)Mahindra, A. / Bolwell, B. / Rybicki, L. / Sobecks, R. / Pohlman, B. / Andresen, S. / Earl, M. / Dean, R. / Copelan, E. / Kalaycio, M. et al. | 2009
- 42
-
Feasibility of CD34-Positive Stem Cell Mobilization by Administration of AMD3100 Six Hours Prior to LeukapheresisChari, A. / Vendivil, M. / Clark-Garvey, S. / Schwartz, J. / Slotky, R. / Diuguid, D. / Savage, D. et al. | 2009
- 42
-
Spontaneous Autologous Acute Graft-Versus-Host Disease (GVHD) in Multiple Myeloma (MM) Autologous Stem Cell Transplant (ASCT) Recipients: A Surprisingly High IncidenceLazarus, H. M. / Subbiah, S. / Wakeling, A. / Cooper, B. W. / Ataergin, S. A. / Laughlin, M. J. / Kindwall-Keller, T. / Creger, R. J. / Barr, P. / Gerson, S. L. et al. | 2009
- 42
-
A MD3100: Successful Mobilization in Patients Who Fail Standard Mobilization With Good Transplant Outcome and No Significant ToxicityKannarkat, G. T. / Beveridge, R. / Eichna, D. / Scherer, D. / Sampl, K. / Salam, A. / Sese, G. B. / Lucy Nam, M. H. / Mintz, K. / Soubra, M. et al. | 2009
- 43
-
Autografting in Acute Myelogenous Leukemia: A Single Center ExperienceLiesveld, J. L. / Nichols, D. / Sanapala, S. / Becker, M. W. / Phillips, G. L. et al. | 2009
- 43
-
Clinical Outcomes With and Without Sargramostim (GM-CSF) Post Autologous Peripheral Blood Stem Cell TransplantationHowle, E. L. / Wolf, R. C. / Burzynski, J. A. / Gastineau, D. A. / Lacy, M. Q. / Gertz, M. A. / Dispenzieri, A. / Kumar, S. / Dingli, D. / Buadi, F. et al. | 2009
- 44
-
Development of A Segment-Based Aldehyde Dehydrogenase Assay to Determine Umbilical Cord Blood Unit (CBU) PotencyShoulars, K. W. / Gentry, T. / Tracy, E. T. / Page, K. / Sun, J. / Winstead, L. / Balber, A. E. / Kurtzberg, J. et al. | 2009
- 44
-
Significant Ex-Vivo Expansion of Cord Blood (CB) Natural Killer (NK) Cells and Concomitant Decrease in CB T-Cells by Genetically Reengineered K562 Cells (K562-mbIL15-41BBL)Hochberg, J. / Mar, B. / Ayello, J. / Day, N. / van de Ven, C. / Ricci, A. / Gurnani, L. / Cairo, E. / Campana, D. / Cairo, M. S. et al. | 2009
- 44
-
Extent of Skeletal Involvement Did Not Predict for Outcome After Autologous Stem Cell Transplant for Patients With Multiple MyelomaSeba, A. / Farhat, M. / Tuncer, H. / Nathan, S. / Gregory, S. A. / Fung, H. C. et al. | 2009
- 45
-
Regulatory T Cell S (Tregs) Can Be Isolated From G-CSF Mobilized PBSC After Monocyte Depletion and Inhibit Anti-Stem Cell T Cell AlloreactivityMahmud, D. / Rondelli, D. et al. | 2009
- 45
-
A "No-Wash" Albumin-Dextran Dilution Strategy for Cord Blood (CB) Thaw is Associated with a High Rate of Engraftment and a Low Incidence of Serious Infusion ReactionsRice, R. D. / Abboud, M. / Hawke, R. M. / Schaible, A. M. / Heller, G. / Scaradavou, A. / Barker, J. N. et al. | 2009
- 45
-
Colony-Forming-Unit (CFU) Assay With High-Resolution Digital Imaging: A Reliable System for Cord Blood (CB) CFU EvaluationAlbano, M. S. / Stevens, C. E. / Dobrila, L. N. / Scaradavou, A. / Rubinstein, P. et al. | 2009
- 46
-
Treatment of Threatening Rejection After Umbilical Cord Blood Transplantation With EX Vivo Expanded Cb Derived T CellsUhlin, M. / Okas, M. / Gertow, J. / Ringden, O. / Mattsson, J. et al. | 2009
- 46
-
Cord Blood Storage Following Collection: Impact on Volume Reduction and CryopreservationMorin, H. / Wagner, E. / Champagne, M. A. et al. | 2009
- 46
-
Standardization of T Cell (CD3+) Dose for Allogeneic Peripheral Blood Stem Cell GraftsInnis-Shelton, R. / Tilden, A. / Ashraf, K. / Vaughan, W. P. / Lamb, L. S. et al. | 2009
- 46
-
Factors Predicting Allogeneic Peripheral Blood Stem Cell (PBSC) Mobilization After G-CSF Treatment in Healthy DonorsBrissot, E. / Chevallier, P. / Guillaume, T. / Delaunay, J. / Ayari, S. / Saulquin, B. / Flandrois, G. / Devys, A. / Stocco, V. / Moreau, P. et al. | 2009
- 47
-
HLA Mismatched MSC Suppress T Lymphocyte Alloresponses in Vitro and do not induce immunological memory in Recipients of MSC InfusionSundin, M. / Barrett, J. / Ringden, O. / Uzunel, M. / Lonnies, H. / Dackland, A. L. / Christensson, B. / Le Blanc, K. et al. | 2009
- 47
-
Double Cord Blood Transplantation (CBT) With Ex-Vivo Expansion (EXP) of One Unit Utilizing A Mesenchymal Stromal Cell (MSC) Platformde Lima, M. / McNiece, I. / McMannis, J. / Hosing, C. / Kebraei, P. / Komanduri, K. / Worth, L. / Staba, S. / Cooper, L. / Petropolous, D. et al. | 2009
- 47
-
The Importance of Graft Cell Composition to Outcome After Allogeneic Stem Cell TransplantationSvenberg, P. / Ringden, O. / Uzunel, M. et al. | 2009
- 48
-
High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem Cell TransplantationCiurea, S. O. / de Lima, M. / Cano, P. / Korbling, M. / McMannis, J. / Giralt, S. / Shpall, E. J. / Champlin, R. E. / Fernandez-Vina, M. et al. | 2009
- 48
-
CD4+Foxp3+ Regulatory T Cells Mediate Suppression of Colony Forming Activity of Leukemic as Well as Primary Myeloid ProgenitorsUrbieta, M. / Levy, R. B. et al. | 2009
- 48
-
Fludarabine, Melphalan and Thiotepa Conditioning for Unrelated Donor Cord Blood TransplantationCiurea, S. O. / Kebriaei, P. / Khouri, I. / Qazilbash, M. / Jones, R. / Petropoulos, D. / Worth, L. L. / Alousi, A. / Hosing, C. / Cano, P. et al. | 2009
- 49
-
The Importance of Blood Cyclosporine Level During Four Weeks After Unrelated Cord Blood Transplantation to Prevent Severe Graft-Versus-Host DiseaseTsukada, N. / Takahashi, S. / Ooi, J. / Tomonari, A. / Mae, H. / Konuma, T. / Kato, S. / Sato, A. / Kasahara, S. / Monma, F. et al. | 2009
- 49
-
Altenative Donor Peripheral Stem Cell Transplant (PSCT) with CD3+ Depletion and CD3+ Addback for Pediatric Patients with LeukemiasBunin, N. / Grupp, S. / Aplenc, R. / Brown, V. / Monos2, D. / Pierson2, G. et al. | 2009
- 49
-
Antibodies Are Detected Against Mismatched HLA Class II Alleles and Not Class I Following Allogeneic Hematopoietic Cell TransplantationArai, S. / Tyan, D. / Vayntrub, T. / Vail, S. / Hassebroek, A. / Brady, C. / Spellman, S. / Miklos, D. et al. | 2009
- 50
-
Reduced-Intensity Cord Blood Transplantation for Adult Patients with Acute Myeloid Leukemia/Myelodysplastic SyndromeTaniguchi, S. / Masuoka, K. / Wake, A. / Uchida, N. / Matsuno, N. / Takagi, S. / Yamamoto, H. / Tsuji, H. / Ishiwata, K. / Yoshimi, M. et al. | 2009
- 50
-
Is There Really a Difference in Outcome and Incidence of Acute/Chronic GVHD in Patients Undergoing Unmanipulated MUD-PBSCT vs MUD-BMT? Single Large Pediatric Center ExperienceKalwak, K. / Porwolik, J. / Gorczynska, E. / Owoc-Lempach, J. / Ussowicz, M. / Musial, J. / Dyla, A. / Pazdzior, D. / Wojcik, D. / Skarzynska, M. et al. | 2009
- 51
-
Diabetes Mellitus (DM) and Hypertension (HTN) in Adult And Pediatric Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT)Majhail, N. S. / Challa, T. R. / Mulrooney, D. A. / Baker, K. S. / Burns, L. J. et al. | 2009
- 51
-
A High Incidence of Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation in Paediatric Patients - A Single Centre ExperienceChan, L. A. / Abdullah, W. A. / Chong, L. A. / Ariffin, H. et al. | 2009
- 51
-
Human Placenta-Derived Stem Cell S (HPDSC) Augment Transplantation with Umbilical Cord BloodYu, L. C. / Faleck, H. / Johnson, K. / Payne, D. / Hariri, R. et al. | 2009
- 51
-
Outcomes of Hematopoietic Stem Cell Transplantation (HCT) From Umbilical Cord Blood (UCB) Units in Patients With Malignant and Non-Malignant Disorders| 2009
- 52
-
Mortality of Hematopoietic Stem Cell Transplant Recipients Admitted to A Medical Intensive Care Unit (MICU) as Predicted by the Hematopoietic Cell Transplantation Comorbidity Index (HCTCI)Miller, S. M. / Rossetti, J. / Sahovic, E. / Hilton, C. / Lister, J. et al. | 2009
- 52
-
Ethical Reasoning About Patient Eligibility in Allogeneic BMT Based on Psychosocial CriteriaFoster, L. W. / McLellan, L. J. / Rybicki, L. A. / Bolwell, B. J. et al. | 2009
- 52
-
Utility of the Psychosocial Assessment of Candidates for Transplantation (PACT) Scale in Allogeneic BMTFoster, L. W. / McLellan, L. J. / Rybicki, L. A. / Bolwell, B. J. et al. | 2009
- 52
-
Avascular Necrosis (AVN) in Survivors of Hematopoietic-Cell Transplantation (HCT): A Large Single Institution StudyMcAvoy, S. / Mulrooney, D. A. / Arora, M. / Baker, K. S. / Burns, L. J. / Majhail, N. S. et al. | 2009
- 53
-
Taste Disorders and Oral Clinic Evaluation in Patients Submitted to Allogeneic Hematopoietic Stem Cell TransplantationBoer, C. / Miranda, E. / Vogorito, A. / Correa, M. E. / de Souza, C. et al. | 2009
- 53
-
Allelic Variation in TP53 and MDM2 DNA Repair Genes Constitute Genetic Risk Factors for Long-Term Survival in Allogeneic Stem Cell TransplantationDupont, B. / Malkki, M. / Gooley, T. / Wang, H. / Zhao, L. P. / Bojesen, S. E. / Petersdorf, E. W. / Hansen, J. A. et al. | 2009
- 53
-
Diagnosis of Mental Health Disorder Does Not Effect Outcome in Allogeneic Bone Marrow TransplantKhan, G. / Sproat, L. / Bolwell, B. / Rybicki, L. / Kalaycio, M. / Dean, R. / Sobecks, R. / Pohlman, B. / Andresen, S. / Sweetenham, J. et al. | 2009
- 54
-
Relative Impact of Psychosocial Factors, Comorbidities, and Disease Risk on the Utilization of Resources and Overall Outcome in Patients Undergoing Hematopoietic Stem Cell TransplantationSpeckhart, D. S. / Holland, H. K. / Solomon, S. R. / Bashey, A. / Morris, L. E. / Kerns, L. / Berry, T. et al. | 2009
- 54
-
Solid Organ Transplantation in Survivors of Hematopoietic Cell Transplantation: A Single Institution Case SeriesBeitinjaneh, A. / Burns, L. / Majhail, N. et al. | 2009
- 55
-
Psychosocial Factors and Overall Survival After Autologous and Allogeneic BMTHahn, T. / Jensen, S. / Lopez, F. / Zevon, M. / Tan, W. / Wilding, G. / Paddon, C. / White, J. / Thomas, J. / Battiwalla, M. et al. | 2009
- 55
-
Suicide in Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) Patients, Is It A Problem?Larsen, H. B. / Petersen, H. / Roepstorff, C. / Sengelow, H. / Heilmann, C. et al. | 2009
- 55
-
Pancreatic Atrophy Is Associated With Gastrointestinal Chronic Graft-Versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell TransplantationNakasone, H. / Ito, A. / Endo, H. / Muramatsu-Kida, M. / Izutsu, K. / Usuki, K. et al. | 2009
- 55
-
A Study on the Sexual Dysfunction of Female Recipients Who Underwent Hematopoietic Stem Cell TransplantationKim, J. W. / Kim, K. S. / Bok, J. N. / Lee, S. Y. et al. | 2009
- 56
-
Related Donor Outcomes From the Japanese Registry - the Importance of Pre-Registration SystemKodera, Y. / Miyamura, K. / Nagafuji, K. / Hino, M. / Kim, S. / Suzuki, R. et al. | 2009
- 56
-
Monoculture-Derived Leukemia and Multivirus Specific Cytotoxic T-Lymphocytes for Immunotherapy of All in Hematopoietic Stem Cell and Umbilical Cord Blood TransplantsMicklethwaite, K. P. / Savoldo, B. / Cooper, L. J. / Schpall, E. J. / Rooney, C. M. / Heslop, H. E. / Brenner, M. K. / Bollard, C. M. / Dotti, G. et al. | 2009
- 56
-
Incidence, Characteristics and Outcome of Cytomegalovirus, Adenovirus, and BK Virus Co-Infection in Pediatric Recipients of Stem Cell TransplantWatcharananan, S. / Kiertburanakul, S. / Premchaiporn, K. / Anurathapan, U. / Sungkanuparph, S. / Chantratita, W. / Pakakasama, S. / Hongeng, S. et al. | 2009
- 57
-
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Advanced Phases of Chronic Myeloid Leukemia (CML) in the Early Imatinib Mesylate (IM) ERAKhoury, H. J. / Kukreja, M. / Wang, T. / Woolfrey, A. / Szer, J. / Cortes, J. / Horowitz, M. M. / Lee, S. et al. | 2009
- 57
-
Sirolimus (SRL)-Based GVHD Prophylaxis After Allogeneic HSCT in Pediatric All Patients: Low NRM, Low Incidence of VOD, and Higher Than Expected EFS: Results of a Multi-Institutional Pilot StudyPulsipher, M. A. / Wall, D. / Grimley, M. / Goyal, R. / Grupp, S. / Bunin, N. et al. | 2009
- 58
-
Combined Risk-Factor Analysis Predicts Outcome of AML Patients After Allogeneic Stem Cell Transplantation Following Reduced Intensity ConditioningHemmati, P. G. / Terwey, T. H. / Massenkeil, G. / le Coutre, P. / Neuburger, S. / Dorken, B. / Arnold, R. et al. | 2009
- 58
-
Post-Hematopoietic Stem Cell Transplantation (HSCT) Outcomes in Patients With AML Transplanted Prior to Achieving Platelet RecoveryAlatrash, G. / Pelosini, M. / Saliba, R. / Rondon, G. / Zhang, W. / Giralt, S. / Kebriaei, P. / Alousi, A. / Khouri, I. / Champlin, R. et al. | 2009
- 58
-
Polyclonal Prame-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid LeukemiaQuintarelli, C. / Dotti, G. / De Angelis, B. / Hoyos, V. / Pane, F. / Mims, M. / Heslop, H. / Rooney, C. M. / Brenner, M. K. / Savoldo, B. et al. | 2009
- 59
-
GVHD Prophylaxis Using Low-Dose Cyclosporine is Safe and Reduces the Risk of Relapse and Death in Leukemic Recipients of HLA-Identical Sibling TransplantsOlsson, R. / Remberger, M. / Mattsson, J. / Hassan, Z. / Ringden, O. et al. | 2009
- 59
-
Conditioning Regimens Prior to Allogeneic Stem-Cell Transplantation (SCT) In Acute Leukemia: The Role Of Dose IntensityShimoni, A. / Rand, A. / Hardan, I. / Shem-Tov, N. / Yerushalmi, R. / Nagler, A. et al. | 2009
- 59
-
Isolated Extra-Medullary Relapse of Acute Leukemia After Allogeneic Stem-Cell Transplantation (SCT); Different Kinetics and Better Prognosis than Systemic RelapseShimoni, A. / Rand, A. / Shem-Tov, N. / Yerushalmi, R. / Hardan, I. / Nagler, A. et al. | 2009
- 60
-
Adoptive T Cell Therapy Using Educated T Cells Generated By the Sequential Stimulation With Dc/Tumor Fusion Cells and Anti-CD3/CD28Rosenblatt, J. / Vasir, B. / Wu, Z. / Zarwan, C. / Stone, R. / Bissonnette, A. / Friedman, T. / Stevenson, K. / Neuberg, D. / Mills, H. et al. | 2009
- 60
-
Prolonged Survival In Adults With Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning With Cord Blood or Sibling Donor TransplantationBachanova, V. / Verneris, M. R. / Brunstein, C. / Weisdorf, D. et al. | 2009
- 60
-
Allogeneic Hematopoietic Cell Transplant (HCT) For Prolymphocytic Leukemia (PLL)Kalaycio, M. / Kukreja, M. / Szer, J. / Woolfrey, A. / Cortes, J. / Arora, M. et al. | 2009
- 60
-
Impaired Pre-Transplant Fev1 is Associated With Reduced Overall and Disease Free Survival Following Allogeneic Transplant for Acute Myelogenous LeukemiaMagenau, J. / Maslak, J. / Mineishi, S. / Digiandamenico, S. / Braun, T. / Levine, J. E. / Yanik, G. A. et al. | 2009
- 61
-
Allogeneic Stem Cell Transplantion In Relapsed/Refractory Acute Leukemia: A Long Term Single Institution ExperienceGo, A. / Stiff, P. J. / Parthasarathy, M. / Rodriguez, T. E. / Smith, S. E. / Brush, M. / Kiley, K. / Payan, M. / Porter, N. / Volle, M. et al. | 2009
- 61
-
Selective Reprogramming of Cd19-Specific T Cells With IL-21 and CD28 Signaling for Adoptive Immunotherapy of Acute Lymphoblastic LeukemiaSingh, H. / Huls, M. H. / Dawson, M. J. / Mi, T. / Lee, D. A. / Kebriaei, P. / Shpall, E. J. / Hackett, P. B. / June, C. H. / Champlin, R. E. et al. | 2009
- 62
-
The Interaction Between Leukemia and Bone Marrow Stroma Protects the Tumor Cells from Chemotherapy- and Radiotherapy-Induced ApoptosisBarriga, F. / Riquelme, E. / Macanas, P. / Besa, P. / Broekhuizen, R. / DiPersio, J. F. / Kalergis, A. / Nervi, B. et al. | 2009
- 62
-
Outcomes Of Allogeneic Stem Cell Transplantation for Patients With Acute Leukemia Transformed from MyelofibrosisCiurea, S. O. / de Lima, M. / Giralt, S. / Alousi, A. / Kebriaei, P. / Khouri, I. F. / Anderlini, P. / Andersson, B. S. / Hosing, C. M. / Champlin, R. E. et al. | 2009
- 62
-
Tolerability and Outcomes of a Targeted Intravenous Busulfan and Fludarabine (T-BU/FLU) Conditioning Regimen for the Treatment De Novo and Secondary Acute Myeloid Leukemia (AML)Fernandez, H. F. / Perkins, J. / Field, T. / Alsina, M. / Ayala, E. / Kharfan-Dabaja, M. / Ochoa, J. L. / Perez, L. / Raychaudhuri, J. / Anasetti, C. et al. | 2009
- 63
-
Sequential Therapy With Nonablative Allogeneic Stem Cell Transplantation, Post Transplant Imatinib and Donor Lymphocyte Infusion for Chronic Myeloid LeukemiaChamplin, R. E. / de Lima, M. / Giralt, S. / Kebriaei, P. / Anderlini, P. / Qazilbash, M. / Hosing, C. / Shpall, E. / Fisher, T. / Gabriela, R. et al. | 2009
- 63
-
Epigenetic Regulations Influence CML Cell Sensitivity to Busulfan: Relevance to Pretransplant Conditioning TherapyValdez, B. C. / Li, Y. / Murray, D. / Champlin, R. E. / Andersson, B. S. et al. | 2009
- 63
-
Reduced Intensity Conditioning (RIC) Regimen Followed By Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients (PTS) With Acute Lymphoblastic Leukemia (ALL)Silva L., D. P. / Saliba, R. / Giralt, S. / Hosing, C. / Khouri, I. / Popat, U. / Qazilbash, M. / Shpall, E. / Thomas, D. / Kantarjian, H. et al. | 2009
- 64
-
Allogeneic Stem Cell Transplantation (SCT) After First Relapse In Adult Patients With Acute Lymphocytic Leukemia (ALL)Arnold, R. / Terwey, T. / Hemmati, P. / le Coutre, P. / Neuburger, S. / Dorken, B. / Massenkeil, G. / Gokbuget, N. et al. | 2009
- 64
-
Safety and Efficacy of Fludarabine and PK-Targeted Intravenous Busulfan Before Allografting for Adult AllAnasetti, C. / Santarone, S. / Alsina, M. / Ayala, E. / Field, T. / Kharfan-Dabaja, M. / Ochoa, L. / Perez, L. / Perkins, J. / Raychaudhuri, J. et al. | 2009
- 64
-
Clofarabine-Induced Remission In Relapsed Pediatric Acute Myelogenous LeukemiaGordon, C. / Megason, G. / Ledbetter, A. et al. | 2009
- 65
-
Bortezomib Targets Stroma-Mediated APO2l/Trail Apoptosis Resistance In Multiple MyelomaPerez, L. E. / Parquet, N. / Anasetti, C. / Dalton, W. et al. | 2009
- 65
-
Fusion Cell Vaccination In Conjunction With Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated With Responses In Patients With Multiple MyelomaAvigan, D. / Rosenblatt, J. / Vasir, B. / Wu, Z. / Bissonnette, A. / Somaiya, P. / MacNamara, C. / Uhl, L. / Avivi, I. / Katz, T. et al. | 2009
- 65
-
Production of Mage-A4-Specific CTL from Healthy Donors, Patients, and Cord Blood for Lymphoma Therapy After TransplantCruz, C. R. / Leen, A. M. / Shafer, J. A. / Younes, A. / Rooney, C. M. / Gerdemann, U. / Christin, A. S. / Heslop, H. E. / Bollard, C. M. et al. | 2009
- 66
-
Stem Cell Mobilization In Patients With Newly Diagnosed Multiple Myeloma Following Therapy With Lenalidomide and DexamethasoneKumar, S. / Lacy, M. Q. / Dispenzieri, A. / Hayman, S. R. / Dingli, D. / Miceli, T. / Litzow, M. R. / Rajkumar, S. V. / Gertz, M. A. et al. | 2009
- 66
-
Tandem Autologous and Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-matched Related Or Unrelated Donors for Advanced Lymphoma Or Chronic Lymphocytic Leukemia (CLL)Sorror, M. L. / Storer, B. / Sandmaier, B. M. / Chauncey, T. / Storb, R. F. / Maloney, D. G. et al. | 2009
- 67
-
Pre-Mobilization Bone Marrow Plasmacytosis Predicts Successful Stem Cell Mobilization In Patients With Multiple Myeloma Receiving Lenalidomide-Based Induction RegimensBenson, D. M. / Hofmeister, C. C. / Hamadani, M. / Panzner, K. / Smith, M. K. / Penza, S. L. / Elder, P. / Krugh, D. / ODonnell, L. / Devine, S. M. et al. | 2009
- 67
-
The "Side-Population" of Human Lymphoma Cells have Increased Chemo-Resistance, Stem-Cell Like Properties and are Potential Targets for ImmunotherapyShafer, J. A. / Leen, A. M. / Cruz, R. / Craddock, J. A. / Heslop, H. E. / Rooney, C. M. / Brenner, M. K. / Bollard, C. M. / Foster, A. E. et al. | 2009
- 67
-
Reduced-Intensity Allogeneic Versus Autologous Peripheral Blood Stem Cell Transplantation In Patients With Hodgkins and Non-Hodgkins LymphomaGutierrez-Aguirre, C. H. / Cantu-Rodriguez, O. G. / Gonzalez-Llano, O. / Jaime-Perez, J. C. / Salazar-Riojas, R. / Martinez-Gonzalez, O. L. / Gutierrez-Riverol, K. I. / Ruiz-Delgado, G. J. / Ruiz-Arguelles, G. J. / Gomez-Almaguer, D. et al. | 2009
- 68
-
Autologous Stem Cell Transplantation (ASCT) In Patients Aged ≥65 Years With Multiple Myeloma: Moffitt Cancer Center ExperiencePaoletti, C. / Balducci, L. / Alsina, M. / Boler, I. / Popa, M. A. / Extermann, M. / Lara-Rivera, S. / Raychaudhury, J. / Anasetti, C. / Fernandez, H. et al. | 2009
- 68
-
Improved Outcome for Allogeneic Transplantation Performed After January 2000Pelosini, M. / Mendoza, F. / Hosing, C. / Popat, U. R. / Anderlini, P. / Alousi, A. M. / Kebriaei, P. / Weber, D. M. / Wang, M. / Champlin, R. E. et al. | 2009
- 68
-
Combination Of Ifn-a/GM-CSF as Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): Results of a Prospective Phase II StudySalmasinia, D. / Moreb, J. S. et al. | 2009
- 69
-
Busulfan and Cyclophosphamide has Similar Outcomes to High Dose Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation In Patients With Multiple MyelomaMahindra, A. / Bolwell, B. / Rybicki, L. / Dean, R. / Pohlman, B. / Sobecks, R. / Andresen, S. / Sweetenham, J. / Kalaycio, M. / Copelan, E. et al. | 2009
- 69
-
Maintenance Therapy With Low Dose Thalidomide, Dexamethasone, and Clarithromycin (BIAXIN) (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)Holmberg, L. A. / Bensinger, W. I. et al. | 2009
- 69
-
High Dose Chemotherapy With Autologous Stem Cell Transplantation for Multiple Myeloma: Achievement Of Complete Remission Is Associated With Improved SurvivalKumar, L. / Ghosh, J. / Ganessan, P. / Gupta, A. / Hariprasad, R. et al. | 2009
- 70
-
Continued M Protein Responses Beyond Day 100 After Autologous Transplantation for Myeloma: Implications for Post Transplant StrategiesKumar, S. / Dispenzieri, A. / Lacy, M. Q. / Hayman, S. / Buadi, F. K. / Dingli, D. / Rajkumar, S. V. / Litzow, M. R. / Gertz, M. A. et al. | 2009
- 70
-
Use of Second Autologous Hematopoietic Stem Cell Transplants for the Treatment of Multiple MyelomaHarris, P. J. / Ririe, D. W. et al. | 2009
- 70
-
Peripheral Blood CD34 Count Can Predict Successful Progenitor Cell Mobilization in Poor Mobiliziers Treated With Plerixafor and G-CSFMicallef, I. N. / Maurer, M. / Ansell, S. M. / Buadi, F. / Dispenzieri, A. / Gastineau, D. A. / Gertz, M. A. / Hayman, S. R. / Hogan, W. J. / Inwards, D. J. et al. | 2009
- 70
-
Selective T-Cell Immunotherapy for B-Cell Lymphoma Under HypoxiaAng, S. O. / Olivares, S. / Shpall, E. / Lee, D. A. / Champlin, R. E. / Yotnda, P. / Gottschalk, S. M. / Cooper, L. J. et al. | 2009
- 71
-
Non-Myeloablative Conditioning and Allogeneic Transplantation for Multiple MyelomaOsman, K. / Elliott, B. / Mandeli, J. / Scigliano, E. / Ross-Dodds, V. / Isola, L. / Grosskreutz, C. et al. | 2009
- 71
-
An Analysis of the Charges Associated With Peripheral Blood Hematopoietic Progenitor Cell (HPC) Mobilization, Collection and Cryopreservation In Patients With Lymphomas Undergoing Autologous Stem Cell TransplantationWalters, K. H. / Hosing, C. / Smith, V. R. / Rhodes, B. A. / Thompson, R. C. / Qazilbash, M. H. / McMannis, J. D. / Alousi, A. / De Lima, M. / Kebriaei, P. et al. | 2009
- 71
-
Safety and Efficacy Of the Busulfan, Cyclophosphamide and Etoposide Preparative Regimen (BUCYE) For Autologous Hematopoietic Stem Cell Transplant (Autohsct) In Patients With Advanced Aggressive NHL (AA-NHL) Over the Age of 60 YearsBorate, U. / Vaughan, W. et al. | 2009
- 72
-
Outcomes of Unrelated Umbilical Cord Blood Transplantation In Pediatric Patients With Primary and Secondary Myelodysplastic SyndromesParikh, S. H. / Mendizabal, A. / Betz-Stablein, B. / Martin, P. L. / Szabolcs, P. / Prasad, V. K. / Driscoll, T. A. / Kurtzberg, J. et al. | 2009
- 72
-
A Phase I/II Study Of Cyclophosphamide and Topotecan In Patients With High-Risk Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation: The St. Jude Long-Term Follow-UpKasow, K. A. / Barfield, R. C. / Wright, N. L. / Li, C. / Srivastava, D. K. / Horwitz, E. M. / Leung, W. / Woodard, P. / Bowman, L. C. / Handgretinger, R. et al. | 2009
- 72
-
Salvage and Hematopoietic Recovery With Bortezomib and Melphalan In Cytopenic Recurrent and Refractory Multiple MyelomaMazumder, A. / Vesole, D. / Jagannath, S. et al. | 2009
- 73
-
Pericardial Effusion Following Unrelated Umbilical Cord Blood Transplantation: Analysis in a Cohort Of 423 Pediatric Patients Transplanted at a Single CenterHwang, E. I. / Camitta, M. G. / Vinesett, R. / Mendizabal, A. / Wood, S. / Semmel, D. / Page, K. / Driscoll, T. A. / Parikh, S. H. / Szabolcs, P. et al. | 2009
- 73
-
Photo(Chemo)Therapy In the Treatment of Cutaneous Chronic Graft Versus Host Disease in Children and AdolescentsLawitschka, A. / Tanew, A. / Seidel, M. / Guclu, E. / Peters, C. et al. | 2009
- 74
-
Intravenous and Intrathecal Enzyme Replacement Before and After Hematopoietic Cell Transplantation for Hurler SyndromeTolar, J. / Dickson, P. / Orchard, P. J. et al. | 2009
- 74
-
Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days In Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Pharmacokinetically Similar to Q6 Hour Dosing in the Pediatric PopulationWaxman, I. / Milone, M. C. / Bhatia, M. / Shaw, L. / Moore, V. / Tallamy, B. / Militano, O. / Garvin, J. H. / George, D. / Bradley, M. B. et al. | 2009
- 74
-
Preengraftment C-Reactive Protein Predicts Infection Risk and Nonrelapse Mortality in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationMcNeer, J. / Duerst, R. / Jacobsohn, D. / Rademaker, A. / Kletzel, M. et al. | 2009
- 75
-
Single Institution Validation of Risk Adjusted Outcomes for 1 Year Mortality In Pediatric Allogeneic Stem Cell Transplantation (HSCT)Duerst, R. E. / Halverson, T. L. / Reynolds, N. / Jacobsohn, D. / Rademaker, A. / Kletzel, M. et al. | 2009
- 75
-
Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (AlloSCT) In Children and Adolescent Recipients is Associated With Very Low Regimen Related and Non-Relapse Mortality (NRM): However, Chemonaive Patients Following Umbilical Cord Blood Transplant (UCBT) have a Higher Incidence of Primary Graft Failure (PGF)Satwani, P. / Tallamy, B. / Jin, Z. / Kohl, V. / Garvin, J. / Bhatia, M. / George, D. / Bradley, B. / van de Ven, C. / Reichman, L. et al. | 2009
- 76
-
Targeting to an Optimal AUC of Intravenous Busulfan Prevents Graft Failure In Transplantation In Children With Non-Malignant DiseasesBartelink, I. H. / Bredius, R. G. / Bierings, M. / Egeler, M. / Lankester, A. C. / Egberts, T. C. / Zwaveling, J. / Boelens, J. J. et al. | 2009
- 76
-
Unrelated Umbilical Cord Blood Transplantation is an Effective Therapy for Wiskott-Aldrich SyndromeSun, J. M. / Driscoll, T. / Prasad, V. K. / Parikh, S. / Szabolcs, P. / Kurtzberg, J. / Martin, P. L. et al. | 2009
- 76
-
Significance Of HLA-B Antigen Matching In Event Free Survival (EFS) In Pediatric Umbilical Cord Blood Transplantation (CBT): Experience from 124 Single CBT At Childrens Memorial Hospital (CMH), CHICAGOMerchant, M. / Chaudhury, S. / Duerst, R. / Jacobsohn, D. / Tse, W. T. / Schneiderman, J. / Kletzel, M. et al. | 2009
- 77
-
Growth and CGVHD In Pediatric Patients Undergoing Reduced Intensity Conditioning for Hematopoietic Stem Cell Transplant As Compared to Traditional Myeloablative ConditioningDanner-Koptik, K. E. / Koss, M. / Duerst, R. / Kletzel, M. / Dilley, K. J. et al. | 2009
- 77
-
Differences In Monitoring and Treatment of Critically ILL Children During or after Hematopoetic Stem Cell TransplantMcArthur, J. A. / Christensen, M. A. / Tamburro, R. F. / Jouvet, P. / Pettersen, G. et al. | 2009
- 77
-
Reduced Intensity Conditioning (RIC) is Associated with a Significant Decrease In Day +100 Non-Relapse Mortality (NRM), Grade II-IV AGVHD and Overall Survival (OS) In Pediatric Recipients Following Cord Blood Transplantation (CBT)Cairo, M. S. / Jin, Z. / van de Ven, C. / Tallamy, B. / Schonfeld, T. / Moore, V. / Harrison, L. / Morris, E. / Bhatia, M. / George, D. et al. | 2009
- 78
-
Survival Following Allogeneic Stem Cell Transplantation for Congenital Immunodeficiency and Metabolic DisordersHorwitz, M. E. / Tunes da Silva, G. / Eapen, M. / Horwitz, E. M. et al. | 2009
- 78
-
Reduced Toxicity Myeloablative Conditioning Regimen with Busulfan, Fludarabine and Alemtuzumab for Children with Non-Malignant Disorders, Myelodysplastic Syndrome (MDS) and Myeloid MalignanciesHorn, B. N. / Dvorak, C. C. / Huang, J. / Englert, L. / Kavanau, K. / Cowan, M. J. et al. | 2009
- 78
-
Second Allogeneic Stem Cell Transplantation (SCT) In Pediatric PatientsAyas, M. / Al-Jefri, A. / Eldali, A. / Al-seraihi, A. / Al-Mahr, M. / Al-Ghonaium, A. / Al-Ahmari, A. / Al-Mousa, H. / Al-Mohsen, S. / Al-Dhekri, H. et al. | 2009
- 79
-
Stable Mixed Chimerism After Non-Myeloablative Transplant for Sickle Cell Disease: Normal Hematopoiesis Dominates Over Abnormal In Mixed ChimerismIldstad, S. / Cheerva, A. / Tollerud, D. / Bertolone, S. / Herzig, G. / Herzig, R. et al. | 2009
- 79
-
Bone Mineral Density, Lean Body Mass, Calcium and Vitamin D Intake In Children and Adolescents After Hematopoietic Stem Cell TransplantationCampos, D. J. / Funke, V. A. / Biagini, G. L. / Kulak, C. A. / Bonfim, C. M. / Zanis Neto, J. / Borba, V. Z. / Boguszewski, C. L. et al. | 2009
- 79
-
Results of Hematopoietic Stem Cell Transplantation In Patients with Leukocyte Adhesion Deficiency Type IHamidieh, A. A. / Pourpak, Z. / Alimoghaddam, K. / Ardalan, M. / Bahoush, G. / Jalili, M. / Movahedi, M. / Moin, M. / Ghavamzadeh, A. et al. | 2009
- 80
-
A Population-Based Single Institution Evaluation Of 16 Years Of Allogeneic HSCT In Childhood AllIfversen, M. / Muller, K. / Jacobsen, N. / Baekgaard, H. / Heilmann, C. et al. | 2009
- 80
-
Prevalence, Risk Factors and Management of Metabolic Syndrome After Stem Cell Transplantation In Pediatric PatientsSoni, S. / Termuhlen, A. / Bajwa, R. P. / Clayton, J. / Montgomery, M. / Hardin, D. et al. | 2009
- 80
-
Reduction of Treatment Related Mortality After Stem Cell Transplantation In Children and Adolescents with all Undergoing Allogeneic Stem Cell Transplantation: The Value Of Severe Adverse Event ReportingSchrauder, A. / Schrappe, M. / Stackelberg, A. / Bader, P. / Peters, C. et al. | 2009
- 81
-
Second Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Lymphoblastic Leukemia (ALL) - an Option to ConsiderDuerst, R. E. / Jacobsohn, D. / Chaudhury, S. / Schneiderman, J. / Tse, W. T. / Kletzel, M. et al. | 2009
- 81
-
Tacrolimus and "Mini" Methotrexate is an Effective Regimen for Prevention of Graft-Versus-Host-Disease In Children Undergoing Umbilical Cord Blood TransplantKelly, S. S. / Kelly, P. / Hunger, S. P. / Wingard, J. R. et al. | 2009
- 81
-
Relationship Between Day 0 Cyclosporine Level and Graft-Versus-Host Disease in Pediatric HSCTDuncan, C. N. / Buonanno, M. R. / Lehmann, L. E. et al. | 2009
- 82
-
Relationship Between Acetaminophen Dosage and Development of Organ Dysfunction During Pediatric Hematopoetic Stem Cell TransplantMcArthur, J. A. / Mikhailov, T. / Rothchild, C. / Talano, J. A. et al. | 2009
- 82
-
Matched Unrelated Bone Marrow Transplant for Omenn SyndromeNahum, A. / Reid, B. / Grunebaum, E. / Roifman, C. M. et al. | 2009
- 82
-
T-Cells Redirected Against NKG2D-Ligands for the Immunotherapy of OsteosarcomaKakarla, S. / Shaffer, D. / Ahmed, N. / Wang, L. L. / Lee, D. A. / Sentman, C. L. / Gottschalk, S. et al. | 2009
- 82
-
Assessment of Lung Function Before and After Allogeneic Hematopoietic Stem Cell Transplantation in a Single Pediatric CenterQuigg, T. C. / Kim, Y. J. / Goebel, W. S. / Spiegel, C. B. / Haut, P. R. et al. | 2009
- 83
-
Depletion of CD4 T Cells Leads to Increased Tumor Immunity After HSCT Immunotherapy but Results In Loss of MemoryJing, W. / Johnson, B. D. et al. | 2009
- 83
-
High Dose Chemotherapy With Blood or Marrow Transplant for Rhabdomyosarcoma: A Cibmtr AnalysisStiff, P. / Agovi, M. A. / Antman, K. / Camitta, B. / Cairo, M. / Childs, R. / Edwards, J. R. / Gale, R. P. / Hale, G. / Horowitz, M. M. et al. | 2009
- 83
-
CCR2b-Transduced Cytotoxic T Lymphocytes Show Enhanced Homing In Vivo Toward CCL2-Secreting Neuroblastoma: Implications for Enhanced Adoptive ImmunotherapyCraddock, J. A. / Lu, A. / Rooney, C. M. / Foster, A. E. et al. | 2009
- 84
-
Allogeneic Stem Cell Immunotherapy for Advanced Metastatic Breast Cancer: The Way ForwardBlaise, D. / Goncalves, A. / Furst, S. / Bay, J. O. / Faucher, C. / Michallet, M. / Boiron, J. M. / Cahn, J. Y. / Gratecos, N. / Mohty, M. et al. | 2009
- 84
-
Low Morbidity and Mortality in a Pilot Study of Busulfan, Melphalan and Topotecan as Preparative Regimen Followed By Autologous Hematopoetic Stem Cell Transplantation In Pediatric Patients With High Risk Solid Tumors (Preliminary Results)Bolotin, E. / Pawlowska, A. / Hitt, D. / Andersen, C. / Shakhnovitz, M. / Sato, J. / Forman, S. / Rosenthal, J. et al. | 2009
- 84
-
Long-Term Follow-Up of Metastatic Renal Cancer Patients Undergoing Reduced-Intensity AllograftingBregni, M. / Bernardi, M. / Pescarollo, A. / Crocchiolo, R. / Treppiedi, E. / Ciceri, F. / Corradini, P. / Peccatori, J. et al. | 2009
- 85
-
Human Embryonic Stem Cells-Derived Hemangioblast Express HLA-AntigensBasak, G. W. / Yasukawa, S. / Alfaro, A. / Miniev, B. / Carrier, E. et al. | 2009
- 85
-
Increased Frequency and Responsiveness of Psa-Specific T Cells After Allogeneic Stem Cell Transplantation for Prostate CancerMattsson, J. / Okas, M. / Ringden, O. / Uhlin, M. et al. | 2009
- 85
-
Complete Long-Term Hematopoietic Engraftment by Lineage-Depleted ALDH CD34+ UCB CellsLiu, C. / DeOliveira, D. / Sempowski, G. D. / Chao, N. J. / Chen, B. J. / Storms, R. W. et al. | 2009
- 86
-
Isolation and Expansion of Oligodendrocytes from Thawed, Cryopreserved Human Umblilical Cord BloodTracy, E. / Gentry, T. / Shoulars, K. / Hughes, M. / Kurtzberg, J. et al. | 2009
- 86
-
Nasal Epithelial Cells of Donor Origin After Allogeneic HCT: Result of Stem-Cell Plasticity, Cell-Fusion or Transfer of Epithelial Cell Precursors with the Graft?Khan, F. / Sy, S. / Louie, P. / Smith, M. / Chernos, J. / Lee, R. / Berka, N. / Sinclair, G. / Leigh, R. / Proud, D. et al. | 2009
- 86
-
Allogeneic Stem Cell Transplantation (Allo-SCT) For Relapsed, Refractory Myeloid Leukemia and Mds Using Clofarabine (Clo) +- Fludarabine (Flu) with IV Busulfan (Bu) As Conditioning TherapyAndersson, B. S. / de Lima, M. / Popat, U. / Jones, R. B. / Shpall, E. J. / Hosing, C. / McAdams, P. L. / Alousi, A. M. / Kebriaei, P. / Champlin, R. E. et al. | 2009
- 87
-
Questioning the Role of A Neutropenic Diet in Hematopoietic Stem Cell TransplantationTrifilio, S. / Pi, J. / Holmes Gobel, B. / Giel, M. / Fishman, M. / Masino, K. / Lucier, E. / Korenaga, Y. / Mehta, J. et al. | 2009
- 87
-
A Randomized, Controlled Trial of Graft-Versus-Host Disease (Gvhd) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of Gvhd, Relapse and SurvivalPerkins, J. / Alsina, M. / Anasetti, C. / Ayala, E. / Fernandez, H. / Kharfan-Dabaja, M. / Ochoa-Bayona, L. / Perez, L. / Raychaudhuri, J. / Sullivan, D. et al. | 2009
- 88
-
Generation of Hla-Restricted T-Lymphocyte Responses Against Recombinant Influenzavirus Hemagglutinin A/New Caledonia by an In Vitro Umbilical Cord Blood Model of Dendritic Cell VaccinationDecker, W. K. / Li, S. / Xing, D. / Robinson, S. N. / Yang, H. / Steiner, D. / Shpall, E. J. / Bollard, C. M. / Safdar, A. et al. | 2009
- 88
-
Severe Hepatocellular Injury after Hematopoietic Cell Transplantation: Incidence, Etiology, and OutcomeSakai, M. / Strasser, S. I. / McDonald, G. B. et al. | 2009
- 88
-
Human Coronavirus (HCOV) and Rhinovirus (HRHV) Infection among Hematopoietic Stem Cell Transplantation (HCT) RecipientsMilano, F. / Campbell, A. P. / Kuypers, J. / Englund, J. A. / Callais, C. / Corey, L. / Boeckh, M. et al. | 2009
- 89
-
Tacrolimus and Sirolimus as GVHD Prophylaxis for Sibling Donor Hematopoietic Stem Cell Transplant (HCT) Using Three Conditioning Regimens; Fludarabine-Melphalan, FTBI-VP16, and Busulfan-CyclophosphamideNakamura, R. / Rodriguez, R. / Palmer, J. / Parker, P. / Nademanee, A. / Shayani, S. / Smith, E. / Karanes, C. / Snyder, D. / ODonnell, M. et al. | 2009
- 89
-
Cytomegalovirus (CMV) Reactivation in Recipients of Umbilical Cord Blood (UCB): Risk Factors and OutcomesBeck, J. C. / DeFor, T. E. / Brunstein, C. G. / Weisdorf, D. J. / Wagner, J. E. / Verneris, M. R. et al. | 2009
- 89
-
Prediction of VOD Using Biomarkers of Endothelial InjuryCutler, C. / Aldridge, J. / Kim, H. T. / Ayanian, S. / Bradwin, G. / Revta, C. / Murga, G. / Ho, V. / Alyea, E. / Koreth, J. et al. | 2009
- 90
-
Higher Costs of Umbilical Cord Blood (Ucb) Transplantation Compared to Hematopoietic Cell Transplantation (Hct) Using Matched Related Donors (Mrd): Influence of Engraftment and Post-Hct ComplicationsMajhail, N. S. / Mothukuri, J. M. / Brunstein, C. G. / Weisdorf, D. J. et al. | 2009
- 90
-
Cost Analysis of Mobilization and Autolgous Transplantation in Patients Who Received Amd3100 after Failing Standard MobilizationDelgado, E. / LeMaistre, C. F. / Bachier, C. / Smith, B. / Lopez-Gonzalez, G. / Hougham, M. / Kaleel, S. / Shaughnessy, P. et al. | 2009
- 90
-
Palifermin for Prevention of Oral Mucositis (OM) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Using A Fractionated Total Body Irradiation (FTBI)-Based Conditioning RegimenShayani, S. / Spielberger, R. T. / Tsai, N. C. / Palmer, J. / Chau, S. / Forman, S. J. et al. | 2009
- 91
-
Preemptive Rituximab Treatment May Reduce the Incidence of Post-Transplant Lymphoproliferative Disorders (Ptld) In Patients with Ebv Reactivation after Allogeneic Stem Cell TransplantationKindwall-Keller, T. L. / Cooper, B. W. / Laughlin, M. J. / Gerson, S. L. / Barr, P. / Erinc, S. / Creger, R. J. / Lazarus, H. M. et al. | 2009
- 91
-
CHG Waterless Bath System Significantly Reduced BSI in Pediatric BMT PatientsRosselet, R. M. / Termuhlen, A. M. / Skeens, M. / Garee, A. / Laudick, M. / Ryan-Wenger, N. et al. | 2009